CollPlant Biotechnologies (CLGN) Operating Expenses (2017 - 2025)

CollPlant Biotechnologies has reported Operating Expenses for 9 years, with the latest figure at $3.0 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 21.93% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (down 39.75% YoY), and the FY2025 full-year result was $13.0 million, down 19.34% from the prior year.
• Operating Expenses for Q4 2025 stood at $3.0 million, down from $3.3 million in the prior quarter.
• The five-year high for Operating Expenses was $4.7 million in Q4 2022, with the low at $92000.0 in Q1 2022.
• Historically, Operating Expenses has averaged $3.5 million across 5 years, with a median of $3.7 million in 2021.
• Annual changes were most pronounced in 2021 — Operating Expenses slumped 99.84% — and 2024, when it soared 1880.61%.
• CollPlant Biotechnologies' Operating Expenses stood at $3.6 million in 2021, then jumped by 31.02% to $4.7 million in 2022, then fell by 1.67% to $4.6 million in 2023, then declined by 15.85% to $3.9 million in 2024, then dropped by 21.93% to $3.0 million in 2025.
• The last three Operating Expenses figures came in at $3.0 million (Q4 2025), $3.3 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.